» Articles » PMID: 10799435

Intestinal Inflammation in Cystic Fibrosis

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 2000 May 9
PMID 10799435
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is controversy about whether the inflammatory response observed in the cystic fibrosis (CF) lung occurs secondary to bacterial infection or is caused by a dysregulation of the inflammatory response associated with the basic cellular defect of CF.

Aims: To study the inflammatory response in the gastrointestinal tract of children with CF; and to investigate whether there is increased inflammation in the gastrointestinal tract of CF children with fibrosing colonopathy.

Methods: Whole gut lavage was performed on 21 pancreatic insufficient children with CF, who were clinically well, five children with CF and fibrosing colonopathy, and 12 controls. Intestinal outputs of plasma derived proteins (albumin, alpha(1) antitrypsin, IgG), secretory immunoglobulins (IgA and IgM), cellular constituents (eosinophil cationic protein and neutrophil elastase), and cytokines (interleukin 8 and interleukin 1beta) were measured.

Results: Compared to controls, the 21 CF patients, with no intestinal complications, had increased intestinal outputs of albumin, IgG, IgM, eosinophil cationic protein, neutrophil elastase, interleukin 1beta, and interleukin 8. Similar values were obtained for the CF patients with fibrosing colonopathy.

Conclusions: These data suggest that there is immune activation in the gastrointestinal mucosa of children with cystic fibrosis, which may result from the basic cellular defect. Fibrosing colonopathy does not appear to be associated with increased inflammation.

Citing Articles

Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?.

Drzymala-Czyz S, Walkowiak J, Colombo C, Alicandro G, Storrosten O, Kolsgaard M iScience. 2024; 27(11):111153.

PMID: 39620135 PMC: 11607544. DOI: 10.1016/j.isci.2024.111153.


Normalization of Cystic Fibrosis Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of Cystic Fibrosis Mice.

Scull C, Hu Y, Jennings S, Wang G Cell Mol Gastroenterol Hepatol. 2024; 19(2):101424.

PMID: 39510500 PMC: 11720009. DOI: 10.1016/j.jcmgh.2024.101424.


Intestinal Inflammation and Regeneration-Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease.

Kwon S, Khan M, Kim S Int J Mol Sci. 2024; 25(2).

PMID: 38279309 PMC: 10816399. DOI: 10.3390/ijms25021311.


Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.

Young S, Woode R, Williams E, Ericsson A, Clarke L Physiol Genomics. 2023; 56(3):247-264.

PMID: 38073491 PMC: 11283905. DOI: 10.1152/physiolgenomics.00077.2023.


Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.

Caley L, White H, de Goffau M, Floto R, Parkhill J, Marsland B Dig Dis Sci. 2023; 68(5):1797-1814.

PMID: 36600119 DOI: 10.1007/s10620-022-07812-1.


References
1.
Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R . The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol. 1995; 20(2):63-70. DOI: 10.1002/ppul.1950200203. View

2.
Bonfield T, Panuska J, Konstan M, Hilliard K, Hilliard J, Ghnaim H . Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995; 152(6 Pt 1):2111-8. DOI: 10.1164/ajrccm.152.6.8520783. View

3.
Croft N, Marshall T, Ferguson A . Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Postgrad Med J. 1996; 72 Suppl 2:S32-6. View

4.
Koller D, Gotz M, Wojnarowski C, Eichler I . Relationship between disease severity and inflammatory markers in cystic fibrosis. Arch Dis Child. 1996; 75(6):498-501. PMC: 1511810. DOI: 10.1136/adc.75.6.498. View

5.
Noah T, Black H, Cheng P, Wood R, Leigh M . Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis. 1997; 175(3):638-47. DOI: 10.1093/infdis/175.3.638. View